RBC Bearings (RBC) Q3 2026 earnings review
A&D Supercycle Drives Record Backlog, Industrial Stalls
RBC Bearings delivered a decisive beat in Q3, fueled by a massive 41.5% surge in Aerospace & Defense sales. The company is riding a 'supercycle' in submarine and commercial aircraft demand, pushing the total backlog to a record $2.1 billion—up from $1.6 billion just three months ago. While the VACCO acquisition contributed significantly to the top line ($29.2M), it weighed on margins. Conversely, the Industrial segment remains stuck in low gear (+3.1% growth), held back by weak OEM demand in oil and semiconductor sectors. Management's tone was exceptionally bullish, citing capacity as the only limit to growth.
🐂 Bull Case
Backlog surged to $2.1 billion, providing exceptional visibility into the 2030s. This is not just future promises; orders are being booked now for long-term defense programs (Virginia/Columbia submarines) and commercial aerospace ramps.
Despite the dilutive impact of the VACCO acquisition (lower gross margins), consolidated Adjusted Gross Margin expanded to 45.1%. As VACCO synergies are realized and volume leverage kicks in, there is a clear path to further expansion.
🐻 Bear Case
Management explicitly stated revenue is 'currently capped by production capacity.' With backlog exploding, execution risk shifts from finding customers to hiring manpower and adding shifts fast enough to deliver.
While A&D booms, the Industrial engine is sputtering. OEM weakness in oil, gas, and semiconductors continues to drag on the segment, which grew only 3.1% despite easy comps.
⚖️ Verdict: 🟢🟢
Strong Bullish. The backlog explosion to $2.1B changes the investment thesis from 'cyclical recovery' to 'secular boom.' The disparity between A&D strength and Industrial weakness matters less when A&D is growing at 40%+.
Key Themes
Aerospace & Defense Supercycle
A&D revenue growth accelerated to 41.5% YoY, driven by what management calls a 'generation-defining' cycle. Demand is robust across both defense (submarines, missiles) and commercial aerospace (Boeing/Airbus build rates). This segment is rapidly approaching revenue parity with the Industrial business.
Capacity Constraints Capping Revenue
A critical bottleneck has emerged: Management admitted revenues are 'capped by production capacity.' While they are adding shifts and hiring, the inability to manufacture fast enough to meet the $2.1B backlog could lead to extended lead times or missed delivery windows in upcoming quarters.
VACCO Margin Dilution
The VACCO acquisition contributed $29.2M in sales but dragged A&D margins down. Organic A&D gross margins would have been ~42.3%, but reported A&D margins were lower due to VACCO's mid-20s margin profile. Management targets a 1,000 bps improvement here over 18-24 months, but execution is key.
Backlog Explosion
Total backlog jumped from $1.6B in Sept 2025 to $2.1B in Dec 2025. This $500M sequential increase reinforces the longevity of the growth story, with some orders extending into the 2030s. $500M of recent growth was attributed to the VACCO acquisition, but organic orders remain very strong.
Deleveraging Focus
Despite the acquisition, RBC is aggressively paying down debt. Interest expense dropped to $13.0M from $14.2M YoY. Management's stated goal is to pay off the term loan by November 2026, utilizing strong free cash flow ($99.1M in Q3).
Industrial OEM Weakness
Industrial OEM sector declined 4.7% in Q2 (trend continuing into Q3 data), with specific weakness in oil, semiconductor machinery, and European machine tools. While distribution is holding up, the OEM side remains a drag on the overall growth rate.
Other KPIs
Accelerating. Up 29.9% YoY ($2.34 in 25Q3) and up sequentially from $2.88 in 26Q2. The earnings power is expanding faster than revenue due to operational leverage.
Accelerating. Up significantly from $73.6M in the prior year. FCF conversion was an impressive 147% of Net Income, indicating high quality of earnings despite working capital needs for the ramp.
Stable. Up only 3.1% YoY. While positive, it lags significantly behind the 41.5% growth in A&D. This segment is effectively serving as a 'cash cow' to fund the A&D expansion.
Guidance
Decelerating slightly sequentially in percentage terms but maintaining high levels. Implies ~14.2% YoY growth at the midpoint (vs 17% in Q3). Excluding VACCO, organic growth is guided at 6.4% - 8.7%.
Stable. The midpoint matches Q3's 45.1%, suggesting the company is effectively managing the dilutive mix shift from VACCO while capturing organic efficiencies.
Key Questions
Capacity Constraints vs. Demand
With revenue 'capped by capacity' and backlog at record highs, what is the specific timeline for new shifts/machinery to come online? Are you losing orders to competitors due to lead times?
VACCO Integration Speed
VACCO is currently dilutive to margins (mid-20s vs corporate 45%). Can you accelerate the 18-24 month timeline for margin synergy, and what are the early wins?
Industrial OEM Recovery
Industrial OEM remains weak in key verticals (Semis, Oil & Gas). Do you see any green shoots in order activity that suggest a turning point in FY27, or is this stagnation structural?